Imperial Innovations has a full pot of cash following its IPO successes of Circassia and Abzena.

Imperial Innovations is looking back on a successful financial year, as the commercialisation arm of Imperial College London has raised £41m ($65.8m) from the initial public offerings of four portfolio companies, including Circassia and Abzena.

Imperial raised £150m earlier in 2014, and now sits on a pot worth £191m, more than doubling its cash from December 2013.

The investment group is hoping it can replicate the successes and is looking towards several portfolio companies to scale up. Indeed, its portfolio companies are hoping to raise £100m over the next 12 months.

While Imperial Innovations has the financial means to participate in rounds of these portfolio companies, it is also hoping to add several companies to its portfolio with an emphasis on value over volume. Keeping in line with that vision, the company is considering increasing its stakes from a curent 30% to closer to 50% for future investments.

Russ Cummings, chief executive at Imperial Innovations, said: “We’ve identified specific companies in our portfolio that we think are ready to scale. We know these businesses, warts and all.”